Data / Drug companies / Bjwc
Bjwc: 56 products in the FDA NDC directory, labeler code 68391
Bjwc (labeler code 68391) lists 56 products in the FDA National Drug Code Directory, covering 32 finished drugs by generic name. By type: 56 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 4, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 68391
- Products in commercial distribution
- 56
- Packages
- 64
- Finished drugs by generic name
- 32
- Prescription products
- 0
- Over the counter products
- 56
- Flagged as original packager
- 50 of 50 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 2
- Earliest marketing start
- April 19, 2003
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 28 | 50% |
| Over the counter monograph drugs | 26 | 46.4% |
| New drug applications (NDA) | 2 | 3.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 56 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 9 | 16.1% |
| Capsule, liquid filled | 6 | 10.7% |
| Tablet | 5 | 8.9% |
| Gum, chewing | 4 | 7.1% |
| Lozenge | 4 | 7.1% |
| Tablet, chewable | 3 | 5.4% |
| Tablet, coated | 3 | 5.4% |
| Solution | 3 | 5.4% |
| Tablet, extended release | 2 | 3.6% |
| Capsule, delayed release | 2 | 3.6% |
| Tablet, delayed release | 2 | 3.6% |
| Capsule | 2 | 3.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Berkley and Jensen Tussin DM Max | 68391-711 | Solution | Over the counter monograph drugs | September 4, 2025 |
| Berkley and jensen rapid release acetaminophen | 68391-411 | Tablet, film coated | Over the counter monograph drugs | September 4, 2025 |
| Berkley and jensen all day allergy | 68391-400 | Tablet, film coated | Generic drugs (ANDA) | September 4, 2025 |
| Extra Strength Acetaminophen PM | 68391-430 | Tablet | Over the counter monograph drugs | September 1, 2025 |
| Low Dose Aspirin | 68391-481 | Tablet, delayed release | Over the counter monograph drugs | August 25, 2025 |
| Nighttime Sleep Aid | 68391-793 | Liquid | Over the counter monograph drugs | August 20, 2025 |
| Stool Softener | 68391-730 | Capsule | Over the counter monograph drugs | August 20, 2025 |
| Mucus Relief | 68391-724 | Tablet, extended release | Generic drugs (ANDA) | August 20, 2025 |
| Gas Relief | 68391-722 | Capsule | Over the counter monograph drugs | August 20, 2025 |
| Nighttime Sleep Aid | 68391-613 | Capsule, liquid filled | Over the counter monograph drugs | August 20, 2025 |
| Ibuprofen | 68391-610 | Capsule, liquid filled | Generic drugs (ANDA) | August 20, 2025 |
| Allergy Relief | 68391-160 | Tablet, film coated | Over the counter monograph drugs | August 20, 2025 |
| Berkley jensen ultra strength | 68391-033 | Tablet, chewable | Over the counter monograph drugs | March 17, 2025 |
| Berkley and jensen acetaminophen | 68391-659 | Tablet | Over the counter monograph drugs | March 21, 2023 |
| Berkley and jensen lansoprazole | 68391-823 | Capsule, delayed release | Generic drugs (ANDA) | October 21, 2022 |
| Berkley jensen allergy relief | 68391-847 | Tablet, film coated | Generic drugs (ANDA) | February 27, 2022 |
| Berkley and Jensen Childrens Allergy Relief | 68391-301 | Tablet, chewable | Generic drugs (ANDA) | January 25, 2022 |
| Berkley and jensen tussin dm | 68391-299 | Solution | Over the counter monograph drugs | January 2, 2022 |
| Berkley and jensen arthritis pain | 68391-205 | Kit | Generic drugs (ANDA) | November 10, 2021 |
| Aspirin Low Dose Safety Coated | 68391-063 | Tablet, coated | Over the counter monograph drugs | August 20, 2021 |
| Berkley and jensen nasal | 68391-721 | Spray, metered | Over the counter monograph drugs | June 4, 2021 |
| Berkley and jensen mucus relief | 68391-000 | Tablet, multilayer, extended release | Generic drugs (ANDA) | April 4, 2021 |
| Stool Softener Laxative | 68391-041 | Capsule, liquid filled | Over the counter monograph drugs | January 31, 2021 |
| Stool Softener Laxative | 68391-853 | Capsule, liquid filled | Over the counter monograph drugs | January 29, 2021 |
| Berkley and jensen sleep aid | 68391-186 | Solution | Over the counter monograph drugs | July 23, 2020 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.